NanoViricides (NNVC)
(Real Time Quote from BATS)
$1.61 USD
+0.11 (7.33%)
Updated Sep 17, 2024 02:50 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for NanoViricides, Inc falls in the month of June .
All items in Millions except EPS data.
6/30/24 | 6/30/23 | 6/30/22 | 6/30/21 | 6/30/20 | |
---|---|---|---|---|---|
Sales | NA | 0 | 0 | 0 | 0 |
Cost Of Goods | NA | 0 | 0 | 0 | 0 |
Gross Profit | NA | 0 | 0 | 0 | 0 |
Selling & Adminstrative & Depr. & Amort Expenses | 0 | 9 | 8 | 9 | 8 |
Income After Depreciation & Amortization | 0 | -9 | -8 | -9 | -8 |
Non-Operating Income | NA | 0 | 0 | 0 | -5 |
Interest Expense | NA | 0 | 0 | 0 | 0 |
Pretax Income | NA | -9 | -8 | -9 | -13 |
Income Taxes | NA | 0 | 0 | 0 | 0 |
Minority Interest | NA | 0 | 0 | 0 | 0 |
Investment Gains/Losses | NA | 0 | 0 | 0 | 0 |
Other Income/Charges | NA | 0 | 0 | 0 | 0 |
Income From Cont. Operations | NA | -9 | -8 | -9 | -13 |
Extras & Discontinued Operations | NA | 0 | 0 | 0 | 0 |
Net Income (GAAP) | NA | -9 | -8 | -9 | -13 |
Depreciation Footnote | 6/30/24 | 6/30/23 | 6/30/22 | 6/30/21 | 6/30/20 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 0 | -8 | -7 | -8 | -7 |
Depreciation & Amortization (Cash Flow) | NA | 1 | 1 | 1 | 1 |
Income After Depreciation & Amortization | 0 | -9 | -8 | -9 | -8 |
Earnings Per Share Data | 6/30/24 | 6/30/23 | 6/30/22 | 6/30/21 | 6/30/20 |
---|---|---|---|---|---|
Average Shares | NA | 11.63 | 11.54 | 10.90 | 5.62 |
Diluted EPS Before Non-Recurring Items | NA | -0.74 | -0.70 | -0.81 | -2.39 |
Diluted Net EPS (GAAP) | NA | -0.74 | -0.70 | -0.81 | -2.39 |
Fiscal Year end for NanoViricides, Inc falls in the month of June .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Cost Of Goods | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | NA | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 1.90 | 2.18 | 2.03 | 3.67 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -1.90 | -2.18 | -2.03 | -3.67 |
Non-Operating Income | NA | 0.05 | 0.08 | 0.10 | 0.11 |
Interest Expense | NA | 0.00 | 0.01 | 0.04 | 0.00 |
Pretax Income | NA | -1.85 | -2.11 | -1.97 | -3.57 |
Income Taxes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -1.85 | -2.11 | -1.97 | -3.57 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -1.85 | -2.11 | -1.97 | -3.57 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | NA | 11.78 | 11.75 | 11.72 | 11.52 |
Diluted EPS Before Non-Recurring Items | NA | -0.16 | -0.18 | -0.17 | -0.31 |
Diluted Net EPS (GAAP) | NA | -0.16 | -0.18 | -0.17 | -0.30 |